226 related articles for article (PubMed ID: 33749769)
1. Evaluation of Reliability and Correlations of Quality Measures in Cancer Care.
Keating NL; Cleveland JLF; Wright AA; Brooks GA; Meneades L; Riedel L; Zubizarreta JR; Landrum MB
JAMA Netw Open; 2021 Mar; 4(3):e212474. PubMed ID: 33749769
[TBL] [Abstract][Full Text] [Related]
2. Practice-Level Variation in Molecular Testing and Use of Targeted Therapy for Patients With Non-Small Cell Lung Cancer and Colorectal Cancer.
Roberts TJ; Kehl KL; Brooks GA; Sholl L; Wright AA; Landrum MB; Keating NL
JAMA Netw Open; 2023 Apr; 6(4):e2310809. PubMed ID: 37115543
[TBL] [Abstract][Full Text] [Related]
3. Rising and Falling Trends in the Use of Chemotherapy and Targeted Therapy Near the End of Life in Older Patients With Cancer.
Fang P; Jagsi R; He W; Lei X; Campbell EG; Giordano SH; Smith GL
J Clin Oncol; 2019 Jul; 37(20):1721-1731. PubMed ID: 31141431
[TBL] [Abstract][Full Text] [Related]
4. Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative.
Wood ME; Kadlubek P; Pham TH; Wollins DS; Lu KH; Weitzel JN; Neuss MN; Hughes KS
J Clin Oncol; 2014 Mar; 32(8):824-9. PubMed ID: 24493722
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Practice Patterns Among Oncologists Participating in the Oncology Care Model.
Walker B; Frytak J; Hayes J; Neubauer M; Robert N; Wilfong L
JAMA Netw Open; 2020 May; 3(5):e205165. PubMed ID: 32421185
[TBL] [Abstract][Full Text] [Related]
6. Development of a Follow-Up Measure to Ensure Complete Screening for Colorectal Cancer.
Ciemins EL; Mohl JT; Moreno CA; Colangelo F; Smith RA; Barton M
JAMA Netw Open; 2024 Mar; 7(3):e242693. PubMed ID: 38526494
[TBL] [Abstract][Full Text] [Related]
7. Risk Adjusting Survival Outcomes in Hospitals That Treat Patients With Cancer Without Information on Cancer Stage.
Pfister DG; Rubin DM; Elkin EB; Neill US; Duck E; Radzyner M; Bach PB
JAMA Oncol; 2015 Dec; 1(9):1303-10. PubMed ID: 26448610
[TBL] [Abstract][Full Text] [Related]
8. The reliability and validity of lung cancer and melanoma clinical quality survival measures.
Pendl-Robinson E; Calkins KL; Simon SE; Barrett K; Poznyak D
Health Serv Res; 2023 Oct; 58(5):1131-1140. PubMed ID: 37669902
[TBL] [Abstract][Full Text] [Related]
9. Aggressive Care near the End of Life for Cancer Patients in Medicare Accountable Care Organizations.
Kim H; Keating NL; Perloff JN; Hodgkin D; Liu X; Bishop CE
J Am Geriatr Soc; 2019 May; 67(5):961-968. PubMed ID: 30969439
[TBL] [Abstract][Full Text] [Related]
10. Association of Oncologist Participation in Medicare's Oncology Care Model With Patient Receipt of Novel Cancer Therapies.
Manz CR; Tramontano AC; Uno H; Parikh RB; Bekelman JE; Schrag D
JAMA Netw Open; 2022 Sep; 5(9):e2234161. PubMed ID: 36173630
[TBL] [Abstract][Full Text] [Related]
11. Measuring Racial Inequities In The Quality Of Care Across Oncology Practices In The US.
Keating NL; Landrum MB; Samuel-Ryals C; Sinaiko AD; Wright A; Brooks GA; Bai B; Zaslavsky AM
Health Aff (Millwood); 2022 Apr; 41(4):598-606. PubMed ID: 35377762
[TBL] [Abstract][Full Text] [Related]
12. Receipt of appropriate surgical care for Medicare beneficiaries with cancer.
Greenberg CC; Lipsitz SR; Neville B; In H; Hevelone N; Porter SA; Weeks C; Jha AK; Gawande AA; Schrag D; Weeks JC
Arch Surg; 2011 Oct; 146(10):1128-34. PubMed ID: 21690439
[TBL] [Abstract][Full Text] [Related]
13. Access to cancer services for rural colorectal cancer patients.
Baldwin LM; Cai Y; Larson EH; Dobie SA; Wright GE; Goodman DC; Matthews B; Hart LG
J Rural Health; 2008; 24(4):390-9. PubMed ID: 19007394
[TBL] [Abstract][Full Text] [Related]
14. Variation in the Types of Providers Participating in Breast Cancer Follow-Up Care: A SEER-Medicare Analysis.
Neuman HB; Schumacher JR; Schneider DF; Winslow ER; Busch RA; Tucholka JL; Smith MA; Greenberg CC
Ann Surg Oncol; 2017 Mar; 24(3):683-691. PubMed ID: 27709403
[TBL] [Abstract][Full Text] [Related]
15. Area-level variations in cancer care and outcomes.
Keating NL; Landrum MB; Lamont EB; Bozeman SR; McNeil BJ
Med Care; 2012 May; 50(5):366-73. PubMed ID: 22437623
[TBL] [Abstract][Full Text] [Related]
16. Evaluating claims-based indicators of the intensity of end-of-life cancer care.
Earle CC; Neville BA; Landrum MB; Souza JM; Weeks JC; Block SD; Grunfeld E; Ayanian JZ
Int J Qual Health Care; 2005 Dec; 17(6):505-9. PubMed ID: 15985505
[TBL] [Abstract][Full Text] [Related]
17. Adoption of Innovative Therapies Across Oncology Practices-Evidence From Immunotherapy.
Carroll CE; Landrum MB; Wright AA; Keating NL
JAMA Oncol; 2023 Mar; 9(3):324-333. PubMed ID: 36602811
[TBL] [Abstract][Full Text] [Related]
18. Quality of end-of-life care between medical oncologists and other physician specialists for Taiwanese cancer decedents, 2001-2006.
Liu TW; Chen JS; Wang HM; Wu SC; Hung YN; Tang ST
Oncologist; 2009 Dec; 14(12):1232-41. PubMed ID: 20007642
[TBL] [Abstract][Full Text] [Related]
19. End-of-life quality metrics among medicare decedents at minority-serving cancer centers: A retrospective study.
Wasp GT; Alam SS; Brooks GA; Khayal IS; Kapadia NS; Carmichael DQ; Austin AM; Barnato AE
Cancer Med; 2020 Mar; 9(5):1911-1921. PubMed ID: 31925998
[TBL] [Abstract][Full Text] [Related]
20. Advancing performance measurement in oncology.
Campion FX; Larson LR; Kadlubek PJ; Earle CC; Neuss MN
Am J Manag Care; 2011 May; 17 Suppl 5 Developing():SP32-6. PubMed ID: 21711075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
